Scarica l'app Stockscreener
4.47
2.76%
0.12
Pre-mercato:
4.49
0.02
+0.45%
Vanda Pharmaceuticals Inc Azioni (VNDA) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
5.09%
52.59
|
50.04 | 47.65 | 50.47 | 47.46 |
Operating Expenses
|
0.03%
91.09
|
91.07 | 58.65 | 60.62 | 56.70 |
| Benefits Costs and Expenses |
0.08%
87.48
|
87.41 | 53.90 | 55.99 | 52.13 |
| Costs And Expenses |
0.03%
91.09
|
91.07 | 58.65 | 60.62 | 56.70 |
| Operating Income/Loss |
6.15%
-38.50
|
-41.03 | -11.00 | -10.15 | -9.235 |
| Income/Loss From Continuing Operations Before Tax |
6.64%
-34.89
|
-37.37 | -6.244 | -5.516 | -4.664 |
| Income Tax Expense/Benefit, Deferred |
2.24%
-7.972
|
-7.797 | -3.088 | -1.234 | -0.246 |
| Income Tax Expense/Benefit |
2.46%
-7.68
|
-7.874 | -0.92 | -0.998 | -0.518 |
| Income/Loss From Continuing Operations After Tax |
7.75%
-27.21
|
-29.49 | -5.324 | -4.518 | -4.146 |
|
Net Income/Loss
|
7.75%
-27.21
|
-29.49 | -5.324 | -4.518 | -4.146 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.80%
58.99
|
58.53 | 58.26 | 58.22 | 57.76 |
| Diluted Average Shares |
0.80%
58.99
|
58.53 | 58.26 | 58.22 | 57.76 |
| Basic Earnings Per Share |
8.00%
-0.46
|
-0.50 | -0.09 | -0.08 | -0.07 |
| Diluted Earnings Per Share |
8.00%
-0.46
|
-0.50 | -0.09 | -0.08 | -0.07 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.64%
0.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):